相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis
Jennifer L. Ersek et al.
CLINICAL LUNG CANCER (2020)
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Hunain Alam et al.
CANCER CELL (2020)
Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential
Jing Hu et al.
CANCER MEDICINE (2019)
Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma
Osamu Gotoh et al.
NATURE COMMUNICATIONS (2019)
Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing
Xin Zhang et al.
HISTOPATHOLOGY (2019)
Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications
Amy Ellen McCart Reed et al.
JOURNAL OF PATHOLOGY (2019)
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
Hongyang Lu et al.
BMC CANCER (2018)
Dissecting KMT2D missense mutations in Kabuki syndrome patients
Dario Cocciadiferro et al.
HUMAN MOLECULAR GENETICS (2018)
Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma
Gregor Krings et al.
MODERN PATHOLOGY (2018)
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
Shilpa S. Dhar et al.
MOLECULAR CELL (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Histone H3 lysine 4 methyltransferase KMT2D
Eugene Froimchuk et al.
GENE (2017)
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas
Charlotte K. Y. Ng et al.
CLINICAL CANCER RESEARCH (2017)
Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities
N. Pecuchet et al.
ANNALS OF ONCOLOGY (2017)
Integrated Molecular Characterization of Uterine Carcinosarcoma
Andrew D. Cherniack et al.
CANCER CELL (2017)
Mutation of cancer driver MLL2 results in transcription stress and genome instability
Theodoros Kantidakis et al.
GENES & DEVELOPMENT (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Jiajun Zhu et al.
NATURE (2015)
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis
Jiyuan Zhang et al.
NATURE MEDICINE (2015)
Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer
J. S. Ross et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
Sian Jones et al.
NATURE COMMUNICATIONS (2014)
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder
Andrew B. Armstrong et al.
MODERN PATHOLOGY (2009)
分享论文
